2024 Nurse Day

Belgian Dermatology Days
22 maart 2024, 08:30 - 14:30
Bruges Meeting & Convention Centre
Nurse Day Pass: €55
Snel naar
Time

Session

Accueil - Ontvangst
08:30 - 09:00
Room 12
The concept of dermatology nurse led consultations (Pre-quiz, teaching of detected lack of knowledge, post-quiz)
  • Prof. Arjen Nikkels (CHU Liège)
  • Dr. Thomas Damsin (CHU liège)
  • Dr. Gilles Absil (CHU Liège)
  • Mrs. Corinne Chapelier (CHU Liège)
09:00 - 12:00
Room 12
Pause - Pauze
12:00 - 13:00
Foyer
Tattoo and body art
  • Dr. Christa De Cuyper (AZ Sint-Jan Brugge-Oostende)
13:00 - 13:30
Room 12
Picolaser and tattoo removal
  • Dr. Nazli Tassoudji (CHU Liège)
13:30 - 14:00
Room 12
Questions et réponses - Vragen en antworden
14:00 - 14:30
Room 12

Sprekers

Christa de cuyper photograph

Christa De Cuyper

Christa De Cuyper has been working for 35 years as a dermatologist at the AZ Sint-Jan in Bruges and retired in 2016 from clinical practice. She is member of the Royal Belgian Society of Dermatology and Venereology and an active member of EADV. From 2016-2023 she was chairperson of the EADV Nurse Working Group and organised several courses for nurses interested in dermatology. Dr. De Cuyper has special interest in dermatological complications with body art and published several articles, book chapters and two books on this topic. She is founding member of the European Society of Tattoo and pigment Research.

Photo Arjen

Arjen Nikkels

Prof. Dr. Arjen F. Nikkels obtained his MD degree in 1990 at the University of Liège, Belgium and his PhD degree on varicella zoster virus diagnostic methods in 1997. Since 2008, he is a full professor of dermatology and head of department at the CHU of Liège, Belgium. He authored and co-authored more than 235 scientific articles (PUBMED hits) and co-authored many dermatology textbooks. His h-index in Google scholar is 30 with 3066 citations and 192 peer-reviewed articles, in Scopus: 27. Five PhD theses have been published. His clinical trial team has participated in more than 70 major psoriasis and atopic dermatitis trials over the last 15 years.